|
ADHD
& Medication: May 31, 2006
|
|
Due to a shortage of child and adolescent psychiatrists more pediatricians and family doctors are being asked to diagnose and treat Attention Deficit Hyperactivity Disorder (ADHD) creating a need for knowledge on current research and the latest information on ADHD medication. Recently Health Canada has up-dated the prescribing information for all drugs indicated for the treatment of ADHD in adults and children. The changes affect the Contraindications, Warnings and Precautions, Dosing recommendations, and Information for the Patient. Many parents as well as adult patients will be asking for clarification on this newly released information and will need reassurance that medication is still a safe choice. In light of this it has become even more important that physicians as well as other medical professionals working with children and adults with ADHD familiarize themselves with the latest scientific research in this area. The Canadian Attention
Deficit Hyperactivity Disorder Resource Alliance (CADDRA) a national
independent not-for-profit organization has published the first Canadian
ADHD Practice Guidelines that outline proper assessment, CADDRA is also providing
a unique opportunity for all those interested in up-dating their knowledge
on ADHD by hosting a unique three-day conference featuring world renowned
speakers presenting on a wide variety of topics. Friday
and Saturday will be of particular interest, but not exclusive to family
physicians, pediatricians, psychiatrists and psychologists. June 23rd
and 24th are fully accredited for physicians and psychologists. Sunday's
topics have been especially chosen to interest educators and parents.
This conference allows attendees to individualize their conference experience
by registering for only the particular days that interest them or all
three days. The
conference takes place on June 23-25, 2006 at the Renaissance Toronto
Airport Hotel.
|
|
Return to DAWN Ontario index page What's
New
|